España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Stories That Matter
Warren Buffett's Berkshire Hathaway Makes Bold $74 Million Bet On This Forgotten Darling Of Dotcom Boom
S&P 500 Ends 2024 23% Higher, Experts See Double-Digit Growth For 2025
Bitwise's Bold Approach: New ETF Targets Bitcoin Powerhouses As Institutional Adoption Soars
S&P 500 Ends 2024 23% Higher, Experts See Double-Digit Growth For 2025
Bitwise's Bold Approach: New ETF Targets Bitcoin Powerhouses As Institutional Adoption Soars
Gold's Shine Fades As Bitcoin ETFs Rise: The New Safe-Haven Champion?
Options Corner: How To Trade IonQ's Potentially Overbought Sentiment Cycle
Gold's Shine Fades As Bitcoin ETFs Rise: The New Safe-Haven Champion?
Options Corner: How To Trade IonQ's Potentially Overbought Sentiment Cycle
25 Years Of Vladimir Putin Marked By War, Devastated Economy: Russian Leader Looks To Trump For Support
Bitcoin, Ethereum, XRP, Dogecoin Trade Sideways On New Year's Eve
Read More...
Stories That Matter Recent News
Stock Of The Day: Is Home Builder Lennar About To Rally?
Shares of Lennar (LEN) are extremely oversold and close to a level that may be support. There is a good chance a new uptrend forms.
'Bring It On': Angry Birds Producer Namit Malhotra Is Ready For The AI Era Of Cinema
DNEG CEO Namit Malhotra sees the benefits of AI storytelling: "It's an incredibly powerful tool, unless you become lazy."
Is SPY Losing Its Spark? The S&P 500's Risk Conundrum
The 'Magnificent 7' mega-cap tech stocks have contributed to aggressive multiple expansion, pushing the S&P 500 index's P/E ratio to 27.9x.
Tesla Q4 Delivery Preview: Will 2024 Stock Gains Hold As Growth Slows?
Tesla stock will likely be in the spotlight on the first trading day of 2025 with delivery figures expected on Jan. 2.
Gas Prices To Fall In 2025, GasBuddy Says: 'Welcome Relief' For Drivers
Drivers can expect lower prices at the pump in 2025. According to GasBuddy's 2025 Fuel Price Outlook released Tuesday, gas prices are expected to fall for a third consecutive year.
Why Is Insurer SiriusPoint Stock Trading Higher On Tuesday?
SiriusPoint buys back shares and warrants from CM Bermuda for $733 million, ending their ownership. Deal strengthens financials and boosts shareholder value.
Constellation Energy: Will AI Power Surge Light Up Stock?
Constellation Energy has seen significant gains in 2024 due to rising demand for energy driven by AI. Short-term challenges may present an opportunity for long-term investors, but caution is advised due to technical signals and valuation concerns.
Brenmiller Energy Shares Surge On Advancing Project For Heineken-Backed Tempo Beverages
Brenmiller Energy signs contractor for flagship project with Tempo Beverages, reducing emissions and saving costs.
UnitedHealth Group CEO Reportedly Says Company Will Hit Financial Records: Exec's Murder, Public Outcry Are Backdrop For Q4 Earnings
UnitedHealth Group reports Q4 financial results Jan. 16. A look at the estimates and how the company is navigating itself forward.
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
Veru jumps after selling FC2 Female Condom business for $18 million, reducing workforce by 90%.
Natural Gas Prices Spike As 'Bone-Chilling' Arctic Blast Approaches
U.S. natural gas futures are pulling back Tuesday after reaching a 52-week high on Monday. Trading remains volatile with an Arctic blast forecast to hit the nation in January.
Chart Industries Lands LNG Deal: Powering Woodside Energy's Louisiana Expansion
Chart Industries, Inc. secures order from Bechtel for Woodside Energy's Louisiana LNG project, boosting clean energy solutions with IPSMR technology.
Why Is Cancer-Focused Verastem Oncology Stock Trading Higher On Tuesday?
Verastem seeks FDA approval for avutometinib in recurrent LGSOC based on trial results, with a decision expected by June 2025.
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
In the Dow Jones Industrial Average, 28 of the 30 components pay dividends. With changes to the components in 2024, dividend yield is smaller overall.
Wizz Air Tackles Engine Issues With New Pratt & Whitney Deal, Sets Stage For Recovery
Wizz Air reaches new deal with RTX's Pratt & Whitney to address engine issues, includes support and compensation through 2026.
MicroAlgo's FULL Adder Quantum Algorithm Sends Stock Skyrocketing - What's Going On?
MicroAlgo, Inc. (MLGO) shares rise 36.25% as they announce a groundbreaking quantum algorithm technology for FULL adder operations in quantum gate computers.
Bitcoin ETF Showdown: IBIT Leads, BITO Grows, BITX Thrills
In the wild west of Bitcoin (CRYPTO: BTC) ETFs, three heavyweights—iShares Bitcoin Trust ETF (NASDAQ:IBIT), ProShares Bitcoin ETF (NYSE:BITO
Coinbase CEO Brian Armstrong Says A Stablecoin Integration On X Would Be 'A Great Feature'
Coinbase (NASDAQ:COIN) CEO Brian Armstrong is interested in collaborating with Elon Musk‘s X platform to enable USDC
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device
The FDA and Nuwellis warn of potential risks linked to AquaFlexFlow UF 500 Plus blood circuits. A recall addresses issues like therapy termination and patient injury risks.
MicroStrategy's Bitcoin Play: Stellar Year, But December Doldrums Loom Large
MicroStrategy Inc (NASDAQ:MSTR) is riding the Bitcoin (CRYPTO: BTC) rollercoaster like no other, but the thrill seems to have hit a steep drop.
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Sangamo Therapeutics regains rights to its hemophilia A gene therapy as Pfizer ends their collaboration. The program showed positive Phase 3 results.
Bitcoin Surges Above $95,500 In 2024 Closing Day: What's Next?
Bitcoin's (CRYPTO: BTC) remains an attractive buy according to the cryptocurrency community, despite closing December almost where it started, down 1.3% over the past 30 days.
Blockchain Company HIVE Digital Plans Texas Relocation & US GAAP Shift - What's On The Cards?
HIVE Digital Technologies announces relocation of headquarters to San Antonio, Texas to drive growth, innovation, and compliance.